These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12968629)

  • 1. [Glucocorticoids: a two-edged sword in tumor therapy?].
    Kelm-Kahl I
    Dtsch Med Wochenschr; 2003 Aug; 128(33):1697. PubMed ID: 12968629
    [No Abstract]   [Full Text] [Related]  

  • 2. A granisetron patch (sancuso).
    Med Lett Drugs Ther; 2008 Dec 15-29; 50(1301-1302):103-4; quiz p 2 following 104. PubMed ID: 19078867
    [No Abstract]   [Full Text] [Related]  

  • 3. Transdermal patch tailors antinausea treatment.
    Morrow T
    Manag Care; 2008 Dec; 17(12):47-8. PubMed ID: 19127767
    [No Abstract]   [Full Text] [Related]  

  • 4. Does increasing the steroid dose enhance the efficacy of the antiemetic combination of granisetron and methylprednisolone in gynecologic cancer patients--a randomized study.
    Lehoczky O; Udvary J; Bagaméri A; Pulay T
    Eur J Obstet Gynecol Reprod Biol; 2004 Mar; 113(1):94-7. PubMed ID: 15036719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of vomiting due to chemotherapy.
    Zulkhairi ; Kar AS
    Acta Med Indones; 2004; 36(4):219-26. PubMed ID: 15931721
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-dose granisetron for postoperative nausea and vomiting prophylaxis.
    Corman SL; Skledar SJ; Ansani NT
    Ann Pharmacother; 2004 Apr; 38(4):710-3. PubMed ID: 14982978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of cyclizine and granisetron alone and in combination for the prevention of postoperative nausea and vomiting.
    Johns RA; Hanousek J; Montgomery JE
    Anaesthesia; 2006 Nov; 61(11):1053-7. PubMed ID: 17042842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granisetron: an update on its clinical use in the management of nausea and vomiting.
    Aapro M
    Oncologist; 2004; 9(6):673-86. PubMed ID: 15561811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granisetron vs ondansetron for prevention of nausea and vomiting in hematopoietic stem cell transplant patients: results of a prospective, double-blind, randomized trial.
    Walsh T; Morris AK; Holle LM; Callander N; Bradshaw P; Valley AW; Clark G; Freytes CO
    Bone Marrow Transplant; 2004 Dec; 34(11):963-8. PubMed ID: 15489869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiemetics: an update and the MASCC guidelines applied in clinical practice.
    Herrstedt J
    Nat Clin Pract Oncol; 2008 Jan; 5(1):32-43. PubMed ID: 18097455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled study comparing two doses of intravenous granisetron (1 and 3 mg) for acute chemotherapy-induced nausea and vomiting in cancer patients: a non-inferiority trial.
    Yonemura M; Katsumata N; Hashimoto H; Satake S; Kaneko M; Kobayashi Y; Takashima A; Kato Y; Takeuchi M; Fujiwara Y; Yamamoto H; Hojo T
    Jpn J Clin Oncol; 2009 Jul; 39(7):443-8. PubMed ID: 19395466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blinded comparison of ondansetron, granisetron, and placebo for prevention of postoperative nausea and vomiting after supratentorial craniotomy.
    Jain V; Mitra JK; Rath GP; Prabhakar H; Bithal PK; Dash HH
    J Neurosurg Anesthesiol; 2009 Jul; 21(3):226-30. PubMed ID: 19543000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tropisetron, ondansetron, and granisetron for control of chemotherapy-induced emesis in Turkish cancer patients: a comparison of efficacy, side-effect profile, and cost.
    Abali H; Celik I
    Cancer Invest; 2007; 25(3):135-9. PubMed ID: 17530482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?
    Hamadani M; Chaudhary L; Awan FT; Khan JK; Kojouri K; Ozer H; Tfayli A
    J Oncol Pharm Pract; 2007 Jun; 13(2):69-75. PubMed ID: 17873106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of a continuous infusion, patient-controlled antiemetic pump for children receiving emetogenic chemotherapy.
    Jones E; Koyama T; Ho RH; Kuttesch J; Shankar S; Whitlock JA; Cartwright J; Frangoul H
    Pediatr Blood Cancer; 2007 Mar; 48(3):330-2. PubMed ID: 16304666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glucocorticoids in oncology].
    de Castro J; Zamora P; González Barón M
    Med Clin (Barc); 1995 Mar; 104(9):349-56. PubMed ID: 7731305
    [No Abstract]   [Full Text] [Related]  

  • 17. First choice for radiation-induced nausea and vomiting--the efficacy and safety of granisetron.
    Goldsmith B
    Acta Oncol; 2004 Sep; 43 Suppl 15():19-22. PubMed ID: 15370626
    [No Abstract]   [Full Text] [Related]  

  • 18. The cardiovascular safety of high-dose intravenous granisetron in cancer patients receiving highly emetogenic chemotherapy.
    Carmichael J; Harris AL
    Cancer Chemother Pharmacol; 2004 Feb; 53(2):123-8. PubMed ID: 14634790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Don't overlook emesis not caused by chemotherapy.
    J Support Oncol; 2006 Feb; 4(2):80-1. PubMed ID: 16502523
    [No Abstract]   [Full Text] [Related]  

  • 20. New antiemetic agents.
    Gralla R
    Clin Adv Hematol Oncol; 2005 May; 3(5):350-2, 382. PubMed ID: 16167009
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.